Centerpoint Advisors, LLC Bristol Myers Squibb CO Transaction History
Centerpoint Advisors, LLC
- $288 Million
- Q3 2024
A detailed history of Centerpoint Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Centerpoint Advisors, LLC holds 375 shares of BMY stock, worth $20,370. This represents 0.01% of its overall portfolio holdings.
Number of Shares
375
Previous 375
-0.0%
Holding current value
$20,370
Previous $16,000
18.75%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding BMY
# of Institutions
2,449Shares Held
1.51BCall Options Held
29.7MPut Options Held
32.1M-
Vanguard Group Inc Valley Forge, PA187MShares$10.1 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.62 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.97 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.05 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.21 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $115B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...